Cyclodextrin Technologies Development Company Profile

15:38 EDT 22nd September 2018 | BioPortfolio

Cyclodextrin Technologies Development, Inc. (CTD), the "Company", was organized as a Florida corporation on August 9, 1990 with operations beginning July, 1992. In May of 1994 the Company became a fully reporting public company listed on the OTC BB under the symbol CTDI.
In 2000, the Company altered its corporate structure to a holding company with subsidiary companies. The OTC BB symbol was changed to CTDH.

CTD Holdings, Inc. (the "Company") was originally formed to market and sell Cyclodextrins and realted products to the food, pharmaceutical, and other industries; it also provided consulting services related to Cyclodextrin Technology.

CTDH, as a holding company, will acquire, create, and invest in companies that will develop, market, and/or sell products containing Cyclodextrins.


27317 NW 78th Avenue
High Springs
United States of America


Phone: 386-454-0887
Fax: 386-454-8134

News Articles [418 Associated News Articles listed on BioPortfolio]

Heterologous expression of cyclodextrin glycosyltransferase from Paenibacillus macerans in Escherichia coli and its application in 2-O-α-D-glucopyranosyl-L-ascorbic acid production

Cyclodextrin glucanotransferase (CGTase) can transform L-ascorbic acid (L-AA, vitamin C) to 2-O-α-D-glucopyranosyl-L-ascorbic acid (AA-2G), which shows diverse applications in food, cosmetic and phar...

20152023 World Cyclodextrin Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 24022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and en...

Econic Technologies completes £5Million investment round

The funding will provide crucial support for the development of future catalyst generations and the expansion of Econic Technologies facilities, thereby accelerating the commercialisation of Econic&rs...

Alliance forms for development of novel AAV capsids and technologies

An alliance has been formed between SIRION Biotech and Heidelberg University Hospital for the development of novel AAV capsids and technologies addressing shortcomings of clinical gene therapy trials.

AU Launches Report on Emerging Technologies Expected to Spur Africa Development

The African Union (AU) High Level Panel on Emerging Technologies (APET) on June 8, 2018 launched three reports on emerging technologies setting the pace for Africa to advance its socio-economic develo...

Collaboration forms for development of kits to analyse biotherapeutic impurity

A licensing and supply agreement has been signed by Gyros Protein Technologies and Cygnus Technologies for the development of immunoassay kits for biotherapeutic impurity analysis.

Nexeraa Technologies Offers New Desktop Drag-and-Drop Application

NEW YORK, April 9, 2018/PRNewswire/ -- Nexeraa Technologies, an open-sourced, non-programmer's freeware development platform that is seeking to transform the lives of everyday Read more...

Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents Gyros Protein Technologies...

PubMed Articles [1472 Associated PubMed Articles listed on BioPortfolio]

Release behavior of allyl sulfide from cyclodextrin inclusion complex of allyl sulfide under different storage conditions.

The stability of allyl sulfide, an organosulfur compound present in garlic oil, in its α-, β-, and γ-cyclodextrin inclusion complexes was investigated under various storage conditions. The complexe...

Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin.

Due to excellent efficacy, low toxicity, and well-defined selectivity, development of new injectable peptides is increasing. However, the translation of these drugs into products for effective oral de...

Application of a simple methodology to analyze Hydroxypropyl-β-Cyclodextrin in urine using HPLC-LS in early Niemann-Pick disease type C patient.

A new methodology, based on high resolution liquid chromatography with light scatterin detector, is applied to analyze Hydroxypropyl-beta-Cyclodextrin (HPβCD) in urine samples of a child affected by ...

Emerging Food Processing Technologies and Factors Impacting their Industrial Adoption.

Innovative food processing technologies have been widely investigated in food processing research in recent years. These technologies offer key advantages for advancing the preservation and quality of...

The Construction of Crowning β-cyclodextrin with Temperature Response and Efficient Properties of Host-Guest Inclusion.

Promoting a drug inclusion proportion in hydrophobic cavity of β-cyclodextrin using simple methods is a highly ambitious task. Herein, we report the crowning β-cyclodextrins formed by intramolecular...

Clinical Trials [2152 Associated Clinical Trials listed on BioPortfolio]

Determining Lipid Content in Stool After Alpha-cyclodextrin

The Investigator hypothesizes that the currently used dose of dietary ingredient alpha-cyclodextrin (α-CD) will result in greater loss of dietary fat in the stool compared with placebo. T...

Study of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to Treat Niemann-Pick Type C1 (NPC1) Disease

This study evaluates the efficacy and safety of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) in patients with neurologic manifestations of Niemann-Pick Type C1 (NPC1) Disease. Approximately ...

Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

This randomized phase II trial studies how well giving topotecan hydrochloride or cyclodextrin-based polymer-camptothecin CRLX101 works in treating patients with recurrent small cell lung ...

Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching

Objectives: This study aims to evaluate the effectiveness of preemptive administration of non-steroidal anti-inflammatory Piroxicam-beta-Cyclodextrin on risk and level of tooth sensitivity...

Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors

CRLX101 (formerly named IT-101) is a conjugate of camptothecin (CPT) and a linear, cyclodextrin-based polymer. IT-101 is designed to increase the exposure of tumor cells to the chemothera...

Companies [2496 Associated Companies listed on BioPortfolio]

Cyclodextrin Technologies Development

Cyclodextrin Technologies Development, Inc. (CTD), the "Company", was organized as a Florida corporation on August 9, 1990 with operations beginning July, 1992. In May of 1994 the Company became a ful...

Shimoda Biotech (pty) Ltd

Shimoda Biotech (Proprietary) Limited ("Shimoda") is a leading South African biopharmaceutical discovery company that focuses on the development of innovative, proprietary drug delivery systems and no...

Insert Therapeutics, Inc

Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our "CyclosertT"...

Gyros Protein Technologies

Gyros Protein Technologies is a leading provider of sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. Formed in M...

AVAX Technologies Inc.

AVAX Technologies is a development stage biopharmaceutical company which is acquiring and developing technologies and products for the treatment of cancer and other life-threatening diseases. The Comp...

More Information about "Cyclodextrin Technologies Development" on BioPortfolio

We have published hundreds of Cyclodextrin Technologies Development news stories on BioPortfolio along with dozens of Cyclodextrin Technologies Development Clinical Trials and PubMed Articles about Cyclodextrin Technologies Development for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cyclodextrin Technologies Development Companies in our database. You can also find out about relevant Cyclodextrin Technologies Development Drugs and Medications on this site too.

Quick Search


Relevant Topic

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Corporate Database Quicklinks

Searches Linking to this Company Record